Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)KANG, Yoon-Koo; JEONG HWAN YOOK; YOUNG SOO PARK et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 139-149, issn 0344-5704, 11 p.Article

Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?YOUNG SOO PARK; HEE SANG HWANG; HYE JIN PARK et al.Human pathology. 2012, Vol 43, Num 3, pp 413-422, issn 0046-8177, 10 p.Article

Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular CarcinomaJEONG EUN KIM; RYOO, Baek-Yeol; RYU, Min-Hee et al.Oncology. 2012, Vol 82, Num 2, pp 119-125, issn 0030-2414, 7 p.Article

Adjuvant Chemotherapy for Small Bowel Adenocarcinoma after Curative SurgeryDONG HOE KOO; YUN, Sung-Cheol; TAE WON KIM et al.Oncology. 2011, Vol 80, Num 3-4, pp 208-213, issn 0030-2414, 6 p.Article

Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled StudyKANG, Yoon-Koo; SUNG SOOK LEE; DOK HYUN YOON et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3824-3829, issn 0732-183X, 6 p.Article

A UGT1A1^*28 and ^*6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancerKIM, Kyu-Pyo; KIM, Ho-Sook; TAE WON KIM et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 6, pp 1609-1617, issn 0344-5704, 9 p.Article

A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous modelsDONG HOE KOO; RYOO, Baek-Yeol; HWA JUNG KIM et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 4, pp 913-921, issn 0344-5704, 9 p.Article

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancerKANG, Yoon-Koo; RYU, Min-Hee; YOO, Changhoon et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 6, pp 1435-1443, issn 0344-5704, 9 p.Article

Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver functionJEONG EUN KIM; RYOO, Baek-Yeol; RYU, Min-Hee et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 5, pp 1285-1290, issn 0344-5704, 6 p.Article

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancerSUN JIN SYM; RYU, Min-Hee; KANG, Yoon-Koo et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 2, pp 373-380, issn 0344-5704, 8 p.Article

FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor-expressing metastatic colorectal cancer patients treated with single-agent cetuximabWU ZHANG; GORDON, Michael; IQBAL, Syma et al.Journal of clinical oncology. 2007, Vol 25, Num 24, pp 3712-3718, issn 0732-183X, 7 p.Article